Furthermore, ANO1 has been shown to stimulate the expression of TGF-β, facilitate the aggregation of tumor-associated fibroblasts, suppress the immunoreactivity of CD8+T cells, and decrease the secretion of TNF-α, granzyme B, and IFN-γ. Here, CD8A is linked to neoplasm.